Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Takeda Completes Divestment of Dry Eye Drug Xiidra to Novartis
July 3, 2019
- Fujifilm Launches New US Company to Develop Allogeneic iPS Cell-Derived Cancer Immunotherapies
July 3, 2019
- Fujifilm to Invest 3 Billion Yen in New Plant in Netherlands to Boost Cell Culture Media Production
July 3, 2019
- Taisho Completes US$1.5 Billion Acquisition of Bristol-Myers’ OTC Unit
July 3, 2019
- Mikitani Resolved to Grow Rakuten Medical into Global Biotech
July 2, 2019
- CheckMate-227 Lung Cancer Data Will Make or Break Opdivo’s Fate: Analyst
July 2, 2019
- JACE Now Eligible for Health Coverage for Epidermolysis Bullosa
July 2, 2019
- ASKA, RaQualia Team Up for Drug Discovery Research, Employing Ion Channel Technology
July 2, 2019
- Takeda’s Medical Unit Revving Up “Patient First Program” as It Looks beyond the Pill
July 1, 2019
- Takeda Advisor Hasegawa, Herald of Takeda Globalization, Steps Down
July 1, 2019
- Ayumi Taps Kiyonori Karasawa as New Chief
June 28, 2019
- Takeda CEO Takes Home 1.75 Billion Yen in FY2018
June 28, 2019
- Japan OKs Companion Diagnostic for Rozlytrek: Chugai
June 28, 2019
- Takeda Shareholders Block Old Guard Group’s Claw-Back Pitch
June 28, 2019
- Takeda Vows 4.6 Billion Yen Commitment to Support Disease Prevention in Developing and Emerging Nations
June 27, 2019
- Ono Grabs Rights to US Biotech’s Metabolic Cancer Drug
June 26, 2019
- Poxel/Sumitomo’s Imeglimin Delivers Again, This Time in Insulin Combo Study
June 26, 2019
- Daiichi Sankyo to Return Rights to 4 Diagnostic Imaging Agents to GE Healthcare
June 26, 2019
- Opdivo Shows No Significant Difference vs Sorafenib in OS for 1st-Line HCC Use in Global PIII: BMS
June 26, 2019
- MSD’s Zerbaxa Now Available in Japan 4 Months after NHI Price Listing; Ensuring Stable Supply
June 26, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…